NewzA growing number of congressional lawmakers are urging the Trump administration to reconsider a new federal rule scheduled to go into effect next month. The regulation has raised significant concerns among legislators that it will restrict Americans from obtaining necessary prescription medications from licensed international pharmacies.
The impending rule impacts the importation of pharmaceuticals from Canada and overseas markets, potentially cutting off a vital alternative source for affordable drugs. Lawmakers are pressing for a pause or revision of the policy to prevent disruptions in medication access for patients relying on these international suppliers.
In-depth summary · AI, neutral